Drugmakers have cautiously navigated through recent geopolitical shifts and supply chain uncertainties, but the waters for global manufacturing are still choppy for the biopharma industry. Listen in to this panel of top CDMO executives as they discuss how we must challenge the status quo and traditional partnership frameworks as we collaborate across the value chain to improve supply chain flexibility and resiliency.